glp-1 patient GPs should support patients for one year after treatment, says NICE Navigating GLP-1 use in therapy

Both medications affect appetite and digestion, and both interact with the metabolic changes of menopause

The program ends on December 31, 2027

Your prescribing physician needs this context to differentiate medication side effects from genuine drug interactions and adjust your regimen accordingly

We believe that everyone deserves access to the tools that can change their metabolic health, and we are here to make that possible

This information is clear on the website, but many patients miss that the first month is discounted and medication is extra

This is one of the most anticipated readouts, as it will provide the broadest picture of retatrutide's weight loss efficacy in a general obesity population